Monday, Jan 4 2021 | Time 17:55 Hrs(IST)
image
  • Nine more test positive in India for new COVID-19 strain
  • 'Nothing formal from BCCI' to shift Brisbane Test: Hockley
  • Octogenarian becomes first person to get Oxford-AstraZeneca vaccine in UK
  • Only fair probe in Srinagar encounter will satisfy families, says Omar
  • Alert in Rajasthan after reports of bird flu cases
  • Govt to start Seaplane service on select routes
  • Seventh round of talks between Govt and farmers' representatives underway
  • SC to hear ex-IPS officer Sajiv Bhatt's plea against life sentence
  • Families of ‘militants’ killed in Srinagar encounter protest, demand fair probe
  • Covid vaccines approval takes Sensex to new high
  • Jaishankar to visit Sri Lanka on Jan 5
  • SC to hear ex-IPS officer Sajiv Bhatt's plea against life sentence
  • Train service to Kempegowda International Airport begins
  • Centre taking up COVID vaccination in big way : Harsh Vardhan
  • India players and staff all test negative for Covid-19
Business EconomyPosted at: Jan 4 2021 4:36PM


Covid vaccines approval takes Sensex to new high

Mumbai, Jan 4 (UNI) The benchmark Sensex rallied 307.82 points on Monday and closed at an all time high 48,176.80 as the investors' sentiments were lifted over emergency approval of two Covid-19 vaccines in India.
The Sensex registered 0.64 per cent increase, while Nifty jumped by 0.82 pc to close at record 14,132.90.
ONGC was the top gainer, rising around 4 per cent, followed by TCS, HCL Tech, Tech Mahindra, Infosys, M&M, HUL and L&T.
On the other hand, Kotak Bank, Bajaj Finance, Asian Paints, Titan and PowerGrid were among the laggards.
India, which has the second-highest Covid-19 infections in the world, on Sunday approved for emergency use two coronavirus vaccines – one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
The country is expected to start a massive immunisation program shortly. Serum Institute of India, the local maker of the AstraZeneca/Oxford vaccine.
In global markets, stock exchanges in Europe as well as in Shanghai, Seoul and Hong Kong ended on a positive note.
UNI PS SB 1635
Tags: #Covid vaccines approval takes Sensex to new high
More News

IDBI Bank launches Video KYC Account Opening (VAO) facility for Savings Bank Accounts

04 Jan 2021 | 5:31 PM

Kolkata, Jan 4 (UNI) IDBI Bank has announced the launch of Video KYC Account Opening (VAO) facility for Savings Bank Accounts.

see more..
Rinac produces mobile ICU facilities for COVID-19 relief with BASF’s Elastopir solutions

Rinac produces mobile ICU facilities for COVID-19 relief with BASF’s Elastopir solutions

04 Jan 2021 | 5:14 PM

Mumbai, Jan 4(UNI) Rinac India (Rinac), India’s leading insulated panel and refrigeration system producer, has recently produced mobile medical Intensive Care Unit (ICU) facilities made with BASF’s Elastopir, a high-quality polyurethane rigid foam insulation solution.

see more..
Nissan to export SUV 'Magnite' to Indonesia, South Africa

Nissan to export SUV 'Magnite' to Indonesia, South Africa

04 Jan 2021 | 4:44 PM

Chennai, Jan 4 (UNI) Nissan Motor India Private Limited
on Monday announced that it would soon export its new
compact SUV 'Magnite' to Indonesia and South Africa.

see more..
NHPC signs supplementary for Ratle HE project in J&K

NHPC signs supplementary for Ratle HE project in J&K

04 Jan 2021 | 4:38 PM

Mumbai, Jan 4 (UNI) NHPC Limited has signed a Supplementary Memorandum of Understanding (MoU) with Jammu and Kashmir State Power Development Corporation Limited (JKSPDCL) and Power Development Department, Govt. of UT of Jammu & Kashmir on January 3, 2021 for implementation of Ratle HE Project (850 MW) in Union Territory of Jammu & Kashmir through a Joint Venture Company (JVC).

see more..

Covid vaccines approval takes Sensex to new high

04 Jan 2021 | 4:36 PM

Mumbai, Jan 4 (UNI) The benchmark Sensex rallied 307.82 points on Monday and closed at an all time high 48,176.80 as the investors' sentiments were lifted over emergency approval of two Covid-19 vaccines in India.

see more..
image